miR-486-5p: A Prognostic Biomarker for Chronic Myeloid Leukemia
Main Authors: | Anupama Ninawe, Sameer Ahmad Guru, Prasant Yadav, Mirza Masroor, Amit Samadhiya, Namrata Bhutani, Naresh Gupta, Richa Gupta, Alpana Saxena |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2021-03-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.1c00035 |
Similar Items
-
PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India
by: Sameer Ahmad Guru, et al.
Published: (2017-10-01) -
MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
by: Jingwei Jiang, et al.
Published: (2018-09-01) -
Cytogenetics' impact on the prognosis of acute myeloid leukemia
by: Monika Gupta, et al.
Published: (2019-04-01) -
The Functional Role of miR-486 in Nasopharyngeal Carcinoma Tumorigenesis
by: Hsin-Lan Su, et al.
Published: (2017) -
Study of Bone Marrow Lymphocyte Subset in Acute Myeloid Leukemia
by: Prasad Dange, et al.
Published: (2021-07-01)